WebOct 6, 2024 · "We are very pleased with the clinical progress of buntanetap," said Maria L. Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio. "In a Phase 2a clinical trial in AD and PD, treatment with buntanetap resulted in statistically significant improvement in motor function in PD patients and cognition in AD patients. With this promising ... WebJan 27, 2024 · “We appreciate the thoughtful and clear feedback from the FDA regarding our clinical program, and we are thrilled with the acceptance of our proposed development plan for buntanetap in Parkinson’s disease,” Maria L. Maccecchini, PhD, founder, president, and CEO of Annovis, said in a press release. Recommended Reading
Annovis Bio Announces FDA Authorization to Proceed with …
WebJun 27, 2024 · DocWire News spoke with Dr. Maria L. Maccecchini, Founder, President, and CEO of Annovis. Dr. Maccecchini spoke to us about the company, and its lead compound, bentanetap, a potential game-changer in the battle against neurogenerative diseases like Alzheimer’s Disease, and Parkinson’s Disease. WebLantern Pharma's Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern's Board of Directors DALLAS, April 26, 2024 /PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN**),** a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (A.I.) and machine learning (ML) platform to … atari japanese shirt
Annovis Bio Inc. ANVS (U.S.: NYSE) - The Wall Street Journal
WebApr 26, 2024 · Dr. Maccecchini has over 30 years of biopharmaceutical experience in the development of novel therapies for Alzheimer's, Parkinson's, and other … WebOct 7, 2024 · "We are very pleased with the clinical progress of buntanetap," said Maria L. Maccecchini, PhD, founder, president, and chief executive officer of Annovis Bio. "In a phase 2a clinical trial in AD and PD, treatment with buntanetap resulted in statistically significant improvement in motor function in PD patients and cognition in AD patients. WebApr 26, 2024 · Dr. Maccecchini has over 30 years of biopharmaceutical experience in the development of novel therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases. She is the founder of Annovis Bio. atari jaguar wiki